# A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy

> **NCT06619847** · PHASE2 · COMPLETED · sponsor: **Vertex Pharmaceuticals Incorporated** · enrollment: 367 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** VX-993
- **DRUG:** HB/APAP
- **DRUG:** Placebo (matched to VX-993)
- **DRUG:** Placebo (matched to HB/APAP)

## Key facts

- **NCT ID:** NCT06619847
- **Lead sponsor:** Vertex Pharmaceuticals Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-29
- **Primary completion:** 2025-05-27
- **Final completion:** 2025-05-27
- **Target enrollment:** 367 (ACTUAL)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06619847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06619847, "A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06619847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*